Latest News - Zimmer Biomet
Top Corporates Hub
Zimmer Biomet
Enovis: Executing Better, But Still Remains Stuck In A Med-Tech No Man's Land
20.08.2026 10:39
Enovis is gaining share in joint reconstruction, leveraging new products and capitalizing on competitor disruptions. Learn more about ENOV stock here.
5 Revealing Analyst Questions From Zimmer Biomet’s Q2 Earnings Call
14.08.2026 09:49
Zimmer Biomet’s second quarter results were driven by strong execution in its hip franchise, robust technology sales, and progress in the U.S. sales force transformation. CEO Ivan Tornos highlighted that new product adoption, such as the Z1 hip stem and OrthoGrid navigation, contributed to above-average growth in the U.S. In addition, increased demand for the company’s technology and data solutions, including capital equipment sales, played a key role. Management attributed the quarter’s perform
Can Stryker's Q2 Recovery and Guidance Support a Stronger Second Half?
13.08.2026 17:49
Stryker enters the second half with Q2 momentum restored, but meeting guidance hinges on production, backlog conversion and managing cyber and supply risks.
Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next?
13.08.2026 17:49
Stryker's 13.6% three-month rally reflects stronger sales, margins and production, but execution risks and a premium peer valuation could test further gains.
Is SYK Worth Buying as Growth Improves but Execution Risks Persist?
13.08.2026 17:49
Stryker's stronger growth, margin gains and product pipeline support the case, but cyber costs, supply constraints and acquisition execution keep risks elevated.
Zimmer Biomet Holdings (ZBH) Following Its Beat And Guidance Lift, Is The Valuation Catching Up?
07.08.2026 05:15
Zimmer Biomet Holdings (ZBH) just paired stronger than expected quarterly results with a guidance increase, as management pointed to solid execution in U.S. hip and technology lines and progress in its sales force restructuring. See our latest analysis for Zimmer Biomet Holdings. Zimmer Biomet Holdings' recent guidance lift and Q2 beat come after a period of mixed returns, with the share price at US$97.19 and a 90-day share price return of 18.05%. However, the 5-year total shareholder return...
Zimmer Biomet (ZBH) Stock Gets Fair Value Bump After Mixed Analyst Views
07.08.2026 03:19
Zimmer Biomet Holdings is back in focus as analysts fine tune their price targets around recent research and earnings news. Targets such as US$110, US$95 and US$93 reflect a mix of supportive and cautious views on how the current share price lines up with execution and growth expectations. As you read on, you will see how these moves fit into the evolving narrative and what to watch next to stay on top of sentiment around Zimmer Biomet Holdings. Stay updated as the Fair Value for Zimmer...
Zimmer (ZBH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
05.08.2026 13:30
While the top- and bottom-line numbers for Zimmer (ZBH) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zimmer Biomet raises full-year outlook after second-quarter earnings beat
05.08.2026 12:57
Zimmer Biomet Holdings (NYSE:ZBH) reported better-than-expected second-quarter results and increased its guidance for the full year, helping lift the medical technology company’s shares more than 4% in pre-market trading. The company posted adjusted earnings of $2.
Zimmer Biomet (NYSE:ZBH) Beats Q2 Earnings Estimates, Shares Gain Over 5%
05.08.2026 12:14
Zimmer Biomet beats Q2 EPS estimates, revenue in line, shares rise 5% on solid orthopedic demand.
Zimmer Biomet (ZBH) Q2 Earnings and Revenues Beat Estimates
05.08.2026 11:45
Zimmer (ZBH) delivered earnings and revenue surprises of +2.99% and +2.25%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zimmer Biomet’s (NYSE:ZBH) Q2 CY2026: Beats On Revenue
05.08.2026 10:53
Medical device company Zimmer Biomet (NYSE:ZBH) announced better-than-expected revenue in Q2 CY2026, with sales up 4.8% year on year to $2.18 billion. Its non-GAAP profit of $2.07 per share was 3% above analysts’ consensus estimates.
Zimmer Biomet Announces Second Quarter 2026 Financial Results
05.08.2026 10:30
Zimmer Biomet Holdings, Inc. (NYSE: ZBH) and (SIX: ZBH) today reported financial results for the quarter ended June 30, 2026. The Company reported second quarter net sales of $2.177 billion, an increase of 4.8% over the prior year period, an increase of 4.7% on a constant currency1 basis and an increase of 4.0% on an organic constant currency1 basis. Net earnings for the second quarter were $198.3 million, or $399.6 million on an adjusted1 basis.
Pacira BioSciences Q2 Earnings Call Highlights
05.08.2026 02:03
Pacira BioSciences (NASDAQ:PCRX) reported second-quarter 2026 revenue growth, led by higher sales of its EXPAREL, ZILRETTA and iovera° products, while highlighting expanded payer coverage, pipeline progress and the completed sale of iovera° to Zimmer Biomet. Total second-quarter revenue rose 6% fro
3 Healthcare Stocks We Find Risky
04.08.2026 04:53
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 16.6% over the past six months, topping the S&P 500 by 9.6 percentage points.
The Best House On The Block Costs The Most: ISRG
29.07.2026 13:46
In the world of robotic surgery, one company is both the undisputed leader and the most expensive name on the shelf, forcing investors to ask if operational brilliance is worth the high price of admission.
Zimmer Biomet Set to Report Q2 Earnings: What's in the Cards?
29.07.2026 12:58
ZBH heads into Q2 earnings with expectations of modest revenue growth as investors watch demand trends across knees, hips and robotics.
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Boston Scientific, Clorox, CrowdStrike, Exxon Mobil, Honeywell International, Intuit, Intuitive Surgical, Levi Strauss, and More
28.07.2026 11:42
Wall Street analysts are busy reshuffling their ratings ahead of the Fed meeting, with surprise double-upgrades, dramatic target cuts, and fresh initiations spanning surgical robots to cybersecurity. Find out which names made the biggest moves today.
Q1 Surgical Equipment & Consumables - Diversified Earnings: Zimmer Biomet (NYSE:ZBH) Earns Top Marks
28.07.2026 01:33
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including Zimmer Biomet (NYSE:ZBH) and its peers.
Intuitive Surgical Stock Is On Sale, But Is The Growth Story Changing?
24.07.2026 12:47
The robotic surgery leader's shares have pulled back, forcing investors to weigh a solid recovery record against new questions in its most important market.